Gender difference in the neuroendocrine regulation of growth hormone axis by selective estrogen receptor modulators

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 4, 2012, Pages

  Birzniece, Vita ^a,b   Sutanto, Surya ^a   Ho, Ken K Y ^a,b  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ESTROGEN RECEPTOR; GROWTH HORMONE; LUTEINIZING HORMONE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C RECEPTOR; TAMOXIFEN; TAMOXIFEN CITRATE; TESTOSTERONE;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; FEMALE; GROWTH HORMONE RELEASE; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; MALE; NEGATIVE FEEDBACK; NEUROENDOCRINE SYSTEM; NORMAL HUMAN; OPEN STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZATION; RECEPTOR BLOCKING; SEX DIFFERENCE; TESTOSTERONE BLOOD LEVEL; TREATMENT DURATION;

AGED; AGED, 80 AND OVER; ARGININE; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LIVER; LUTEINIZING HORMONE; MALE; MIDDLE AGED; NEUROSECRETION; PITUITARY GLAND, ANTERIOR; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SEX CHARACTERISTICS; SEX HORMONE-BINDING GLOBULIN; TAMOXIFEN; TESTOSTERONE;

EID: 84859534666     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-3347     Document Type: Article

References (28)

1. Weissberger AJ, Ho KK 1993 Activation of the somatotropic axis by testosterone in adult males: evidence for the role of aromatization. J Clin Endocrinol Metab 76:1407-1412 (Pubitemid 23164352)
2. Birzniece V, Sata A, Sutanto S, Ho KK 2010 Paracrine regulation of growth hormone secretion by estrogen in women. J Clin Endocrinol Metab 95:3771-3776
3. Leung KC, Doyle N, Ballesteros M, Sjogren K, Watts CK, Low TH, Leong GM, Ross RJ, Ho KK 2003 Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. Proc Natl Acad Sci USA 100:1016-1021 (Pubitemid 36183947)
4. Weissberger AJ, Ho KK, Lazarus L 1991 Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab 72:374-381 (Pubitemid 21921702)
5. Löfgren L, Wallberg B, Wilking N, Fornander T, Rutqvist LE, Carlström K, von Schoultz B, von Schoultz E 2004 Tamoxifen and megestrol acetate for postmenopausal breast cancer: diverging effects on liver proteins, androgens, and glucocorticoids. Med Oncol 21:309-318 (Pubitemid 40065482)
6. Riggs BL, Hartmann LC 2003 Selective estrogen-receptor modulators - mechanisms of action and application to clinical practice. N Engl J Med 348:618-629 (Pubitemid 36210865)
7. Rochira V, Zirilli L, Genazzani AD, Balestrieri A, Aranda C, Fabre B, Antunez P, Diazzi C, Carani C, Maffei L 2006 Hypothalamicpituitary- gonadal axis in two men with aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback. Eur J Endocrinol 155:513-522 (Pubitemid 44608425)
8. Birzniece V, Sata A, Sutanto S, Ho KK 2010 Neuroendocrine regulation of growth hormone and androgen axes by selective estrogen receptor modulators in healthy men. J Clin Endocrinol Metab 95: 5443-5448
9. Fideleff HL, Frigeri AE, Sobrado PG, Llano MN, Ruibal GF, Boquete HR 1999 Reproducibility and variability of the arginine test in normal adults. Comparison between sexes. Medicina 59:249-253
10. Wolthers T, Hoffman DM, Nugent AG, Duncan MW, Umpleby M, Ho KK 2001 Oral estrogen antagonizes the metabolic actions of growth hormone in growth hormone-deficient women. Am J Physiol Endocrinol Metab 281:E1191-E1196 (Pubitemid 34001193)
11. Gibney J, Johannsson G, Leung KC, Ho KK 2005 Comparison of the metabolic effects of raloxifene and oral estrogen in postmenopausal and growth hormone-deficient women. J Clin Endocrinol Metab 90:3897-3903 (Pubitemid 41058148)
12. Gibney J, Wolthers T, Johannsson G, Umpleby AM, Ho KK 2005 Growth hormone and testosterone interact positively to enhance protein and energy metabolism in hypopituitary men. Am J Physiol Endocrinol Metab 289:E266-E271 (Pubitemid 41076627)
13. Veldhuis JD, Mielke KL, Cosma M, Soares-Welch C, Paulo R, Miles JM, Bowers CY 2009 Aromatase and 5α-reductase inhibition during an exogenous testosterone clamp unveils selective sex steroid modulation of somatostatin and growth hormone secretagogue actions in healthy older men. J Clin Endocrinol Metab 94:973-981
14. Veldhuis JD, Metzger DL, Martha Jr PM, Mauras N, Kerrigan JR, Keenan B, Rogol AD, Pincus SM 1997 Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: evidence from pubertal pathophysiology and sex-steroid hormone replacement. J Clin Endocrinol Metab 82:3414-3420 (Pubitemid 27419097)
15. Yan M, Jones ME, Hernandez M, Liu D, Simpson ER, Chen C 2004 Functional modification of pituitary somatotropes in the aromatase knockout mouse and the effect of estrogen replacement. Endocrinology 145:604-612 (Pubitemid 38183802)
16. Rochira V, Zirilli L, Maffei L, Premrou V, Aranda C, Baldi M, Ghigo E, Aimaretti G, Carani C, Lanfranco F 2010 Tall stature without growth hormone: four male patients with aromatase deficiency. J Clin Endocrinol Metab 95:1626-1633
17. Gooren LJ, van der Veen EA, van Kessel H, Harmsen-Louman W 1984 Estrogens in the feedback regulation of gonadotropin secretion in men: effects of administration of estrogen to agonadal subjects and the antiestrogen tamoxifen and the aromatase inhibitor delta'-testolactone to eugonadal subjects. Andrologia 16:568-577 (Pubitemid 15221153)
18. Corsello SM, Rota CA, Putignano P, Della Casa S, Barnabei A, Migneco MG, Vangeli V, Barini A, Mandalà M, Barone C, Barbarino A 1998 Effect of acute and chronic administration of tamoxifen on GH response to GHRH and on IGF-I serum levels in women with breast cancer. Eur J Endocrinol 139:309-313 (Pubitemid 28430543)
19. Mandalà M, Moro C, Ferretti G, Calabro MG, Nolè F, Rocca A, Munzone E, Castro A, Curigliano G 2001 Effect of tamoxifen on GH and IGF-1 serum level in stage I-II breast cancer patients. Anticancer Res 21:585-588 (Pubitemid 32267576)
20. Cheung C, Yu AM, Chen CS, Krausz KW, Byrd LG, Feigenbaum L, Edwards RJ, Waxman DJ, Gonzalez FJ 2006 Growth hormone determines sexual dimorphism of hepatic cytochrome P450 3A4 expression in transgenic mice. J Pharmacol Exp Ther 316:1328-1334 (Pubitemid 43345309)
21. Kelly JJ, Rajkovic IA, O'Sullivan AJ, Sernia C, Ho KK 1993 Effects of different oral oestrogen formulations on insulin-like growth factor- I, growth hormone and growth hormone binding protein in postmenopausal women. Clin Endocrinol (Oxf) 39:561-567 (Pubitemid 23323955)
22. Takahashi Y, Iida K, Takahashi K, Yoshioka S, Fukuoka H, Takeno R, Imanaka M, Nishizawa H, Takahashi M, Seo Y, Hayashi Y, Kondo T, Okimura Y, Kaji H, Kitazawa R, Kitazawa S, Chihara K 2007 Growth hormone reverses nonalcoholic steatohepatitis in a patient with adult growth hormone deficiency. Gastroenterology 132:938-943 (Pubitemid 46454267)
23. Ichikawa T, Nakao K, Hamasaki K, Furukawa R, Tsuruta S, Ueda Y, Taura N, Shibata H, Fujimoto M, Toriyama K, Eguchi K 2007 Role of growth hormone, insulin-like growth factor 1 and insulinlike growth factor-binding protein 3 in development of non-alcoholic fatty liver disease. Hepatol Int 1:287-294
24. Maffei L, Murata Y, Rochira V, Tubert G, Aranda C, Vazquez M, Clyne CD, Davis S, Simpson ER, Carani C 2004 Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. J Clin Endocrinol Metab 89:61-70 (Pubitemid 38183860)
25. Nishino M, Hayakawa K, Nakamura Y, Morimoto T, Mukaihara S 2003 Effects of tamoxifen on hepatic fat content and the development of hepatic steatosis in patients with breast cancer: high frequency of involvement and rapid reversal after completion of tamoxifen therapy. AJR Am J Roentgenol 180:129-134 (Pubitemid 36008699)
26. Birzniece V, Meinhardt U, Gibney J, Johannsson G, Baxter RC, Seibel MJ, Ho KK 2010 Modulatory effect of raloxifene and estrogen on the metabolic action of growth hormone in hypopituitary women. J Clin Endocrinol Metab 95:2099-2106
27. Birzniece V, Meinhardt UJ, Umpleby MA, Handelsman DJ, Ho KK 2011 Interaction between testosterone and growth hormone on whole-body protein anabolism occurs in the liver. J Clin Endocrinol Metab 96:1060-1067
28. Birzniece V, Meinhardt UJ, Gibney J, Johannsson G, Armstrong N, Baxter RC, Ho KK 14 December 2011 Differential effects of raloxifene and estrogen on body composition in growth hormone-replaced hypopituitary women. J Clin Endocrinol Metab 10.1210/jc.2011-2837